Tag Archives: MC

Top 5 Undervalued Stocks To Watch For 2019

Timing can be everything. It certainly made a difference when CONSOL Energy (NYSE:CEIX) completed its spin-off from CNX Resources, which was confusingly previously named CONSOL Energy. The new spin-off is flying under the same flag, but it took all of the former parent company’s coal assets. With the American coal industry experiencing an awakening of sorts, the stock has jumped nearly 50% since relisting.

The sudden appreciation in value could mean any number of things. Perhaps CONSOL Energy was undervalued at the time of its spin-off. Perhaps it earned a higher valuation, or has convinced Wall Street that the business is poised to thrive in the near future. Or perhaps this is the latest example of an irrational market, and the coal company is overvalued.

What do the numbers indicate? Is CONSOL Energy a buy?

Image source: Getty Images.

Top 5 Undervalued Stocks To Watch For 2019: Aimia Inc. (GAPFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Aimia (OTCPK:GAPFF) (TSX: AIM, AIM.PR.A, AIM.PR.B, AIM.PR.C)

    As some background, we are intimately familiar with Aeroplan and Air Canada (OTCQX:ACDVF) not just as investors but as extraordinarily heavy consumers. As both an Air Canada top tier elite and Aeroplan top tier member I generate well in excess of 1.5 million Aeroplan miles annually, half from flying Air Canada and its partners and the other half from spending. As consumers we were concerned with Air Canada’s decision (though we expect more details to come out that will alleviate these concerns) but as investors we understand that the fundamental business model of mileage programs are incredibly attractive and that Aimia presents an incredibly rare and lucrative investment opportunity for the investor discerning enough to dig into the company.

  • [By ]

    The preferred shares for Aimia (OTCPK:GAPFF) offer an attractive investment return of 28%, assuming redemption, in contrast to the common shares which are trading at their fair value. We believe the market is under-pricing the preferred shares.

Top 5 Undervalued Stocks To Watch For 2019: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NavCoin (CURRENCY:NAV) traded up 3.1% against the US dollar during the 24 hour period ending at 12:00 PM ET on May 14th. NavCoin has a market cap of $69.58 million and approximately $924,266.00 worth of NavCoin was traded on exchanges in the last day. Over the last week, NavCoin has traded 12.8% lower against the US dollar. One NavCoin coin can now be bought for $1.11 or 0.00012616 BTC on cryptocurrency exchanges including LiteBit.eu, Upbit, cfinex and Poloniex.

  • [By Logan Wallace]

    Global X Management Co LLC grew its position in Navistar International Corp (NYSE:NAV) by 20.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 23,073 shares of the company’s stock after acquiring an additional 3,989 shares during the period. Global X Management Co LLC’s holdings in Navistar International were worth $940,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    NavCoin (NAV) is a PoW/PoS coin that uses the X13 hashing algorithm. It launched on June 6th, 2014. NavCoin’s total supply is 62,938,003 coins. The Reddit community for NavCoin is /r/NavCoin and the currency’s Github account can be viewed here. NavCoin’s official Twitter account is @NavCoin. The official website for NavCoin is www.navcoin.org. The official message board for NavCoin is medium.com/nav-coin.

  • [By Rich Smith]

    Navistar (NYSE:NAV) stock had a tough time of things on Thursday. Posting its fifth-in-a-row earnings beat, Navistar nonetheless missed sales estimates slightly — and investors sold off its stock by 8.5%.

Top 5 Undervalued Stocks To Watch For 2019: Moelis & Company(MC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Moelis & Co (NYSE: MC) and Monroe Capital (NASDAQ:MRCC) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations.

  • [By Motley Fool Transcribers]

    Moelis & Company  (NYSE:MC)Q4 2018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Moelis & Co (NYSE:MC) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $62.17.

  • [By Shane Hupp]

    Los Angeles Capital Management & Equity Research Inc. raised its position in shares of Moelis & Co (NYSE:MC) by 57.5% during the second quarter, HoldingsChannel reports. The firm owned 15,006 shares of the asset manager’s stock after purchasing an additional 5,480 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in Moelis & Co were worth $880,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Moelis & Co (NYSE:MC) shares traded down 8.7% during mid-day trading on Thursday . The stock traded as low as $60.85 and last traded at $61.10. 920,800 shares changed hands during mid-day trading, an increase of 131% from the average session volume of 398,993 shares. The stock had previously closed at $66.95.

Top 5 Undervalued Stocks To Watch For 2019: LightPath Technologies, Inc.(LPTH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Headlines about LightPath Technologies (NASDAQ:LPTH) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LightPath Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 46.9867601112654 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 5 Undervalued Stocks To Watch For 2019: Morningstar, Inc.(MORN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    MAN Grp PLC/ADR (NASDAQ: MORN) and Morningstar (NASDAQ:MORN) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

  • [By Ethan Ryder]

    Northern Trust Corp grew its position in Morningstar, Inc. (NASDAQ:MORN) by 4.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 227,049 shares of the business services provider’s stock after buying an additional 9,963 shares during the quarter. Northern Trust Corp’s holdings in Morningstar were worth $21,688,000 at the end of the most recent reporting period.

  • [By Motley Fool Staff]

    Morningstar (NASDAQ:MORN) is perhaps best known for its five-star mutual fund rating system, but there’s a lot more to the company.

    In this Industry Focus: Financials clip, host Shannon Jones and Motley Fool contributor Matt Frankel discuss how Morningstar makes its money and why it’s the best-performing large financial sector stock of this year, thus far.

Top Warren Buffett Stocks For 2019

Besides Warren Buffett, John Malone is one of the featured CEOs in William Thorndike’s great book, “The Outsiders: Eight Unconventional CEOs & Their Radically Rational Blueprint For Success”.

Thorndike describes how John Malone at the start of his career – while he was at McKinsey – got more and more intrigued by the cable television business. Three things in particular caught his attention:

highly predictable, utility-like revenues; favorable tax characteristics; and the fact that it was growing like a weed.

Prudent cable operators could successfully shelter their cash flow from taxes by using debt to build new systems and by aggressively depreciating the costs of construction. These substantial depreciation charges reduced taxable income as did the interest expense on the debt, with the result that well-run cable companies rarely showed net income, and as a result, rarely paid taxes, despite very healthy cash flows.

Related to this central idea was Malone’s realization that maximizing earnings per share, the Holy Grail for most public companies at that time, was inconsistent with the pursuit of scale in the nascent cable television industry. To Malone, higher net income meant higher taxes, and he believed that the best strategy for a cable company was to use all available tools to minimize reported earnings and taxes, and fund internal growth and acquisitions with pretax cash flow.

Top Warren Buffett Stocks For 2019: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Gp Zgp (NASDAQ:ZAIS) major shareholder Z Acquisition Llc bought 6,500,000 shares of the company’s stock in a transaction on Wednesday, September 5th. The stock was bought at an average price of $4.10 per share, with a total value of $26,650,000.00. Following the completion of the acquisition, the insider now owns 6,500,000 shares in the company, valued at $26,650,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Top Warren Buffett Stocks For 2019: Moelis & Company(MC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Moelis & Co (NYSE:MC) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $62.17.

  • [By Shane Hupp]

    Los Angeles Capital Management & Equity Research Inc. raised its position in shares of Moelis & Co (NYSE:MC) by 57.5% during the second quarter, HoldingsChannel reports. The firm owned 15,006 shares of the asset manager’s stock after purchasing an additional 5,480 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in Moelis & Co were worth $880,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribers]

    Moelis & Company  (NYSE:MC)Q4 2018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Warren Buffett Stocks For 2019: Bruker Corporation(BRKR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s rankings:

    Get Bruker alerts:

    Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018 (finance.yahoo.com) Financial Review: Bruker (BRKR) versus Pacific Biosciences of California (PACB) (americanbankingnews.com) Global Microbiology Testing/Clinical Microbiology Market 2018-2024: Market is Influenced by Biomerieux, Abbott, Roche, Bruker and Bio-rad Labs (bizjournals.com) Bruker Corporation appoints Gerald Herman as CFO (seekingalpha.com) Bruker Corporation Appoints Gerald Herman as Chief Financial Officer (finance.yahoo.com)

    A number of brokerages have issued reports on BRKR. Zacks Investment Research cut Bruker from a “buy” rating to a “hold” rating in a research report on Friday. BTIG Research set a $42.00 target price on Bruker and gave the stock a “buy” rating in a research report on Sunday, May 6th. BidaskClub raised Bruker from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. Bank of America decreased their target price on Bruker from $37.00 to $34.00 and set a “neutral” rating for the company in a research report on Friday, May 4th. Finally, Leerink Swann upped their target price on Bruker from $32.00 to $34.00 and gave the stock a “market perform” rating in a research report on Friday, February 9th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $32.91.

Top Warren Buffett Stocks For 2019: Popular, Inc.(BPOP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Dimensional Fund Advisors LP raised its position in Popular Inc (NASDAQ:BPOP) by 3.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,519,087 shares of the bank’s stock after purchasing an additional 150,692 shares during the quarter. Dimensional Fund Advisors LP owned 4.42% of Popular worth $188,084,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Popular (NASDAQ:BPOP) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

Top 10 Performing Stocks To Invest In Right Now

&l;a href=&q;http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=t&a;amp;tab=searchtabquotesdark&q; target=&q;_blank&q;&g;AT&a;amp;T&a;rsquo;s&l;/a&g; stock has been underperforming somewhat over the last year, declining from as&a;nbsp;high as $41 in 2017 to around $32 currently on account of a mixed performance in the wireless business, headwinds in the U.S. pay-TV market and regulatory uncertainty surrounding its planned acquisition of media behemoth Time Warner. In this note, we take a look at some of the factors impacting AT&a;amp;T and what&a;rsquo;s driving our price estimate for the company.

We have created an &l;strong&g;&l;a href=&q;http://dashboards.trefis.com/no-login-required/CdmAAGny?fromforbesandarticle=why-atts-stock-has-been-underperforming&q; target=&q;_blank&q;&g;interactive dashboard analysis&l;/a&g; &l;/strong&g;which outlines our expectations for AT&a;amp;T over 2018. You can modify key drivers to arrive at your own forecasts for the company&a;rsquo;s revenues and EPS. Here is more on how&a;nbsp;&l;a href=&q;https://www.trefis.com/?fromforbesandarticle=why-att-stock-underperforming&q; target=&q;_blank&q;&g;&l;strong&g;i&l;/strong&g;&l;b&g;nstitutional investors and private equity firms &l;/b&g;&l;/a&g;&l;span&g;leverage Trefis technology.&l;/span&g;

Top 10 Performing Stocks To Invest In Right Now: FormFactor, Inc.(FORM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Victory Capital Management Inc. increased its stake in shares of FormFactor, Inc. (NASDAQ:FORM) by 12.1% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,884,057 shares of the semiconductor company’s stock after buying an additional 203,451 shares during the period. Victory Capital Management Inc.’s holdings in FormFactor were worth $25,058,000 at the end of the most recent reporting period.

  • [By Brian Feroldi]

    FormFactor (NASDAQ:FORM), which manufactures testing equipment for semiconductor components, reported its second-quarter results on Wednesday, and as expected, the company posted year-over-year declines in revenue and profits. However, the declines were not as bad as management had projected. Margins also held up well during the trying period. Traders bid up the stock in response to the better-than-expected quarterly results and on the hope that the bottom is in the rearview mirror.

  • [By Max Byerly]

    Shares of FormFactor, Inc. (NASDAQ:FORM) have been assigned a consensus rating of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $17.90.

  • [By Stephan Byrd]

    FormFactor (NASDAQ:FORM) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a report released on Monday.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Liberty TripAdvisor Holdings, Inc.(LTRPA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 30 percent to $12.05 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 26 percent to $14.48 after the company posted better-than-expected Q1 earnings.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 31 percent to $12.10 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 34 percent to $15.3628 after the company posted better-than-expected Q1 earnings.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 32 percent to $12.175 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 27 percent to $14.60 after the company posted better-than-expected Q1 earnings.

  • [By Ethan Ryder]

    Engineers Gate Manager LP acquired a new position in Liberty Tripadvisor Holdings Inc Series A (NASDAQ:LTRPA) during the second quarter, Holdings Channel reports. The fund acquired 102,003 shares of the technology company’s stock, valued at approximately $1,642,000.

Top 10 Performing Stocks To Invest In Right Now: China Pharma Holdings Inc.(CPHI)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get Scynexis alerts:

    Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) (oracleexaminer.com) Do Analysts Think You Should Buy – SCYNEXIS Inc (NASDAQ: SCYX) (stockspen.com) Notable Runner: SCYNEXIS, Inc. (SCYX) (nasdaqplace.com) Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … (journalfinance.net) Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (stocksnewspoint.com)

    Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.

Top 10 Performing Stocks To Invest In Right Now: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Most people who think about retail focus on the hot products that are always in demand. Yet at the other end of the spectrum are the products that perhaps were once needed but now find themselves either out of fashion or no longer necessary for the typical customer. That’s where Liquidity Services (NASDAQ:LQDT) comes in, offering a way for government and private sector clients to dispose of surplus inventory effectively and efficiently. That niche has challenges of its own, but the company has been making moves to build its business back up and hopefully return to profitability.

  • [By Joseph Griffin]

    Eagle Boston Investment Management Inc. grew its stake in Liquidity Services, Inc. (NASDAQ:LQDT) by 4.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,736 shares of the business services provider’s stock after purchasing an additional 12,917 shares during the quarter. Eagle Boston Investment Management Inc. owned approximately 0.96% of Liquidity Services worth $2,015,000 as of its most recent SEC filing.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Liquidity Services (NASDAQ:LQDT) last issued its quarterly earnings data on Thursday, May 3rd. The business services provider reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. Liquidity Services had a negative net margin of 12.72% and a negative return on equity of 19.31%. The company had revenue of $43.10 million during the quarter, compared to the consensus estimate of $60.16 million. equities analysts forecast that Liquidity Services, Inc. will post -0.71 earnings per share for the current year.

Top 10 Performing Stocks To Invest In Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of DBV Technologies (NASDAQ:DBVT) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DBV Technologies (DBVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of DBV Technologies (NASDAQ:DBVT) hit a new 52-week low on Tuesday . The stock traded as low as $20.00 and last traded at $20.31, with a volume of 2187 shares trading hands. The stock had previously closed at $20.07.

Top 10 Performing Stocks To Invest In Right Now: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Exelon (EXC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Skba Capital Management LLC reduced its stake in Exelon Co. (NYSE:EXC) by 1.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 199,350 shares of the energy giant’s stock after selling 2,000 shares during the quarter. Skba Capital Management LLC’s holdings in Exelon were worth $8,492,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    US Bancorp DE trimmed its position in shares of Exelon (NYSE:EXC) by 9.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,712 shares of the energy giant’s stock after selling 15,626 shares during the quarter. US Bancorp DE’s holdings in Exelon were worth $6,153,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Investors sold shares of Exelon Co. (NYSE:EXC) on strength during trading hours on Thursday. $15.04 million flowed into the stock on the tick-up and $55.72 million flowed out of the stock on the tick-down, for a money net flow of $40.68 million out of the stock. Of all stocks tracked, Exelon had the 21st highest net out-flow for the day. Exelon traded up $0.32 for the day and closed at $44.44

  • [By Garrett Baldwin]

    By following a few simple steps, one IRS directive could help set you up to receive checks of up to $1,795 every single month. Hordes of Americans have already signed their names to the distribution list – and the longer you wait, the greater your risk of missing out on this powerful investment. Click here for more details.

    Three Stocks to Watch Today: FB, AAPL, TSLA
    Shares of Facebook Inc. (NASDAQ: FB) are under pressure after another government took action on the social media giant’s data policies. German regulators announced yesterday that they would limit the company’s ability to collect and combine consumer data and target advertising across all of its services. This ruling could make it far more difficult for the firm if it integrates the messaging platforms of Instagram, Messenger, and WhatsApp. Shares of Apple Inc. (NASDAQ: AAPL) are in focus after news broke that it shifted its modem chip engineering team from its supply chain to its internal hardware group. Reuters suggests that it is aiming to develop modem chips in-house after years of buying them from companies like Qualcomm Inc. (NASDAQ: QCOM) and Intel Corp. (NASDAQ: INTC). Such a change could bolster company profits in a big way in the future. Money Morning Chief Investment Strategist Keith Fitz-Gerald argues that Apple stock is a bargain right now. It’s just one of several that tap into the unstoppable investment trends that can make you very rich. Learn more right here. On Monday (Feb. 4), Tesla Inc. (NASDAQ: TSLA) announced it was acquiring Maxwell Technologies Inc. (NASDAQ: MXWL), a battery and ultra-capacitor company. This might seem like a typical acquisition where a larger company scales its output by buying a smaller competitor. This is a much different move… On Friday, look for earnings reports from Arconic Inc. (NASDAQ: ARNC), Exelon Corp. (NYSE: EXC), Hasbro Inc. (NYSE: HAS), Phillips 66 (NYSE: PSX), and Ventas Inc. (NYSE: VTR).
    Millions of Americans Now Entitled to

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Exelon (EXC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Moelis & Company(MC)

Advisors’ Opinion:

  • [By Max Byerly]

    Moelis & Co (NYSE:MC) shares traded down 8.7% during mid-day trading on Thursday . The stock traded as low as $60.85 and last traded at $61.10. 920,800 shares changed hands during mid-day trading, an increase of 131% from the average session volume of 398,993 shares. The stock had previously closed at $66.95.

  • [By Logan Wallace]

    Moelis & Co (NYSE:MC) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $62.17.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Moelis & Co (MC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: CME Group Inc.(CME)

Advisors’ Opinion:

  • [By Logan Wallace]

    Epoch Investment Partners Inc. grew its holdings in shares of CME Group Inc (NASDAQ:CME) by 51.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,545,562 shares of the financial services provider’s stock after purchasing an additional 528,198 shares during the period. Epoch Investment Partners Inc.’s holdings in CME Group were worth $249,980,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    CME Group Inc (NASDAQ:CME) Director Ronald A. Pankau sold 260 shares of the firm’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $163.17, for a total transaction of $42,424.20. Following the transaction, the director now directly owns 3,900 shares in the company, valued at approximately $636,363. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Commonwealth Bank of Australia raised its holdings in CME Group Inc (NASDAQ:CME) by 18.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,969 shares of the financial services provider’s stock after purchasing an additional 4,160 shares during the period. Commonwealth Bank of Australia’s holdings in CME Group were worth $4,413,000 at the end of the most recent reporting period.

  • [By Simon Erickson]

    The fourth quarter brought significant market volatility, as investors saw stock prices fall during the final few months of 2018. But CME Group (NASDAQ:CME), the operator of one of America’s largest options and derivatives exchanges, handsomely benefited. Trading volumes related to equity and interest-rate futures tend to spike during volatile times, which is why CME Group enjoyed a boost to its top and bottom lines. 

  • [By Logan Wallace]

    Investors sold shares of CME Group Inc (NASDAQ:CME) on strength during trading hours on Wednesday. $43.03 million flowed into the stock on the tick-up and $84.28 million flowed out of the stock on the tick-down, for a money net flow of $41.25 million out of the stock. Of all stocks tracked, CME Group had the 11th highest net out-flow for the day. CME Group traded up $0.26 for the day and closed at $170.48

Top 10 Performing Stocks To Invest In Right Now: Qorvo, Inc.(QRVO)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    Investors didn’t waste any time expressing their disappointment after Qorvo’s (NASDAQ:QRVO) fourth-quarter 2018 results came out. The chipmaker failed to offer strong guidance for the current quarter, which was enough to blind investors to the fact that it did well to turn its business around to some extent in the previous quarter.

  • [By Joseph Griffin]

    Qorvo Inc (NASDAQ:QRVO) has been given a consensus recommendation of “Hold” by the twenty-seven analysts that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and ten have given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $83.41.

  • [By Joseph Griffin]

    Qorvo (NASDAQ:QRVO) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Saturday.

  • [By Harsh Chauhan]

    Qorvo (NASDAQ:QRVO) was one of the first Apple suppliers to issue a warning in mid-November, making it clear that weak demand for flagship smartphones will affect its fiscal third-quarter performance. That wasn’t surprising, as Apple supplied more than a third of the chipmaker’s revenue last fiscal year. But there’s a chance of Qorvo surprising investors with a sunny forecast when it releases its official fiscal third-quarter results on Feb. 7. Here’s why.

Top 5 High Tech Stocks To Buy Right Now

Sandstorm Gold (NYSEMKT:SAND) is not a typical streaming/royalty company. Apart from running a portfolio of streams and royalties, the company also holds a few equity stakes in mining companies. As a result, it is a little bit hard to value the company’s shares. In this article, using a simple valuation model, I would like to show that Sandstorm’s shares are undervalued now.

Introduction

As I noted above, Sandstorm holds two main asset classes:

Streaming/royalty portfolio Equity portfolio

The first class may be valued using the discount cash flow model. In its financial reports, the company discloses all relevant conditions at which it had entered each stream and royalty agreement as for example: duration, price at which the metals are to be acquired, the amount of metals under agreement, etc.

Having this data, I can easily find the discounted value of each stream and royalty.

As for equities, I have focused on three main equity stakes held by the company. To find their value, I am using two methods:

Top 5 High Tech Stocks To Buy Right Now: Liberty Broadband Corporation(LBRDK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about Liberty Broadband Corp Series C (NASDAQ:LBRDK) have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Liberty Broadband Corp Series C earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.2592060171908 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Max Byerly]

    Liberty Broadband Corp Series C (NASDAQ: LBRDK) and Roku (NASDAQ:ROKU) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top 5 High Tech Stocks To Buy Right Now: Transportadora De Gas Sa Ord B(TGS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TransCanada (NYSE: TRP) and Transportadora de Gas del Sur (NYSE:TGS) are both oils/energy companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

  • [By Max Byerly]

    News stories about Transportadora de Gas del Sur (NYSE:TGS) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Transportadora de Gas del Sur earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned news coverage about the energy company an impact score of 46.2643511773395 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Joseph Griffin]

    Transportadora de Gas del Sur (NYSE: TGS) and Western Gas Equity Partners (NYSE:WGP) are both oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

  • [By Joseph Griffin]

    Freestone Capital Holdings LLC increased its stake in Transportadora de Gas del Sur SA (NYSE:TGS) by 56.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 177,803 shares of the energy company’s stock after purchasing an additional 64,160 shares during the quarter. Freestone Capital Holdings LLC owned approximately 0.11% of Transportadora de Gas del Sur worth $3,617,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Transportadora de Gas del Sur (NYSE: TGS) and Antero Midstream Partners (NYSE:AM) are both mid-cap oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Top 5 High Tech Stocks To Buy Right Now: Moelis & Company(MC)

Advisors’ Opinion:

  • [By Max Byerly]

    Moelis & Co (NYSE:MC) shares traded down 8.7% during mid-day trading on Thursday . The stock traded as low as $60.85 and last traded at $61.10. 920,800 shares changed hands during mid-day trading, an increase of 131% from the average session volume of 398,993 shares. The stock had previously closed at $66.95.

  • [By Shane Hupp]

    Moelis & Co (NYSE: MC) and Monroe Capital (NASDAQ:MRCC) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Moelis & Co (MC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy Right Now: Vaalco Energy Inc(EGY)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Lisa Levin] Gainers
    Cara Therapeutics, Inc. (NASDAQ: CARA) rose 18.2 percent to $13.71 in pre-market trading. Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma entered into ex-U.S. licensing agreement to commercialize KORSUVA™ injection in dialysis patients with pruritus.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10.6 percent to $2.20 in pre-market trading after surging 12.43 percent on Tuesday.
    VAALCO Energy, Inc. (NYSE: EGY) rose 10.5 percent to $2.37 in pre-market trading after dropping 10.04 percent on Tuesday.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.3 percent to $7.15 in pre-market trading after falling 16.03 percent on Tuesday.
    Tiffany & Co. (NYSE: TIF) rose 7.8 percent to $110.25 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 7.1 percent to $2.13 in pre-market trading. after climbing 12.43 percent on Tuesday.
    Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) rose 5.9 percent to $20.01 in pre-market trading after reporting positive Phase 2 Part B data showing treatment with palovarotene significantly reduces new bone growth in patients with FOP.
    Under Armour, Inc. (NYSE: UA) rose 3.5 percent to $18.44 in pre-market trading.
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) shares rose 3.5 percent to $2.95 in pre-market trading.
    MetLife, Inc. (NYSE: MET) rose 3.2 percent to $50.00 in pre-market trading after reporting a $1.5 billion buyback plan.
    Lowe's Companies, Inc. (NYSE: LOW) rose 3.2 percent to $88.51 in pre-market trading. Lowe's reported downbeat results for its first quarter on Wednesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Cara Therapeutics, Inc. (NASDAQ: CARA) shares jumped 28.5 percent to $14.91 in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million.
    EVO Payments, Inc. (NASDAQ: EVOP) rose 21.5 percent to $19.44. EVO Payments priced its IPO at $16 per share.
    Tiffany & Co. (NYSE: TIF) jumped 16.3 percent to $118.92 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance.
    Ralph Lauren Corporation (NYSE: RL) shares gained 13.4 percent to $132.225 after the company reported stronger-than-expected results for its fourth quarter.
    OneSmart International Edun Gr Ltd – ADR (NYSE: ONE) shares rose 12.2 percent to $13.52
    Heat Biologics, Inc. (NASDAQ: HTBX) shares gained 11.4 percent to $2.2164 after surging 12.43 percent on Tuesday.
    USA Technologies, Inc. (NASDAQ: USAT) rose 10.4 percent to $13.02 after announcing pricing of public offering.
    KemPharm, Inc. (NASDAQ: KMPH) gained 10.3 percent to $6.725. Janney Capital initiated coverage on KemPharm with a Buy rating.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10 percent to $2.1894 after climbing 12.43 percent on Tuesday.
    Lowe's Companies, Inc. (NYSE: LOW) rose 9.5 percent to $93.92. Lowe's reported downbeat results for its first quarter on Wednesday.
    xG Technology, Inc. (NASDAQ: XGTI) jumped 9.1 percent to $0.829 after the company’s subsidiary IMT Vislink received a $1.4 million order from the U.S. Air Force.
    VAALCO Energy, Inc. (NYSE: EGY) rose 8.6 percent to $2.34 after dropping 10.04 percent on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 8.4 percent to $34.99. American Equity Investment Life confirmed preliminary talks related to a potential deal.
    Boxl

Top 5 High Tech Stocks To Buy Right Now: Cumberland Pharmaceuticals Inc.(CPIX)

Advisors’ Opinion:

  • [By Logan Wallace]

    JW Asset Management LLC cut its stake in Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) by 32.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 178,942 shares of the specialty pharmaceutical company’s stock after selling 84,939 shares during the period. Cumberland Pharmaceuticals comprises about 1.2% of JW Asset Management LLC’s holdings, making the stock its 16th largest holding. JW Asset Management LLC owned about 1.14% of Cumberland Pharmaceuticals worth $1,195,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Cumberland Pharmaceuticals (CPIX) Research Coverage Started at B. Riley” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3364464/cumberland-pharmaceuticals-cpix-research-coverage-started-at-b-riley.html.